Biocryst Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 23.89 M | $238.93 M | 5.48% | 9.39% |
| STATE STREET CORP | 09/22/2026 | 15.19 M | $151.91 M | 24.43% | 6.27% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 15.83 M | $158.27 M | 0.00% | 6.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 15.10 M | $150.96 M | 0.39% | 5.93% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 11.36 M | $113.64 M | 2.05% | 4.47% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 11.14 M | $111.39 M | -0.94% | 4.38% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 11.02 M | $110.21 M | 0.00% | 4.33% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 10.31 M | $103.09 M | 38.67% | 4.05% |
| JUPITER TOPCO LLC | 08/14/2026 | 9.54 M | $95.27 M | 100.00% | 3.75% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 8.30 M | $83.00 M | 18.15% | 3.26% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 6.78 M | $67.75 M | 5.99% | 2.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 6.25 M | $62.49 M | 8.05% | 2.46% |
| ABRDN PLC | 07/31/2026 | 5.31 M | $53.11 M | 5.36% | 2.09% |
| UBS GROUP AG | 08/13/2026 | 5.08 M | $50.78 M | 2.72% | 2.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 4.80 M | $48.01 M | -5.70% | 1.89% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 4.48 M | $44.82 M | 90.93% | 1.76% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 4.01 M | $40.09 M | 0.00% | 1.58% |
| NUVEEN, LLC | 08/11/2026 | 4.01 M | $40.07 M | 4.92% | 1.57% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 3.39 M | $33.95 M | 1,708.39% | 1.33% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 3.17 M | $31.71 M | -2.14% | 1.25% |
| JANE STREET GROUP, LLC | 08/14/2026 | 2.76 M | $27.63 M | 343.73% | 1.09% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 2.72 M | $27.19 M | 1.05% | 1.07% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 2.60 M | $26.04 M | -4.73% | 1.02% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 2.53 M | $25.30 M | 225.65% | 0.99% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 2.52 M | $25.23 M | -55.59% | 0.99% |
| CANDRIAM S.C.A. | 08/13/2026 | 2.51 M | $25.13 M | 9.97% | 0.99% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 2.35 M | $23.53 M | 0.12% | 0.92% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 2.35 M | $23.53 M | 100.00% | 0.92% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2026 | 2.33 M | $23.32 M | 4.57% | 0.92% |
| NORTHERN TRUST CORP | 08/13/2026 | 2.26 M | $22.56 M | 7.17% | 0.89% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.21 M | $22.14 M | 403.09% | 0.87% |
| MORGAN STANLEY | 08/13/2026 | 2.00 M | $20.00 M | -1.15% | 0.79% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 1.90 M | $19.01 M | -4.34% | 0.75% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 1.87 M | $18.66 M | -38.63% | 0.73% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 1.85 M | $18.52 M | 29.95% | 0.73% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 08/13/2026 | 1.84 M | $18.45 M | 50.35% | 0.73% |
| STIFEL FINANCIAL CORP | 08/12/2026 | 1.83 M | $18.26 M | 0.06% | 0.72% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.76 M | $17.60 M | 5.72% | 0.69% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.76 M | $17.59 M | 72.68% | 0.69% |
| JUPITER ASSET MANAGEMENT LTD | 08/10/2026 | 1.64 M | $16.43 M | 37.32% | 0.65% |
| IMC-CHICAGO, LLC | 08/06/2026 | 1.63 M | $16.34 M | 158.89% | 0.64% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 1.62 M | $16.24 M | -4.91% | 0.64% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 1.46 M | $14.56 M | 3.14% | 0.57% |
| OP ASSET MANAGEMENT LTD | 07/28/2026 | 1.34 M | $13.41 M | 7.03% | 0.53% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 1.25 M | $11.95 M | 165.02% | 0.49% |
| INVESCO LTD. | 08/14/2026 | 1.23 M | $12.34 M | -5.73% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.20 M | $11.96 M | -57.53% | 0.47% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 1.17 M | $11.74 M | -9.84% | 0.46% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 1.12 M | $11.20 M | 39.90% | 0.44% |
| HRT FINANCIAL LP | 08/14/2026 | 1.08 M | $10.82 M | 100.00% | 0.43% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biocryst Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 438 institutional investors and hedge funds held shares of Biocryst Pharmaceuticals Inc.. The most heavily invested institutionals were:
DOLIVER ADVISORS, LP: 304,328
Farther Finance Advisors, LLC: 6,138
GAMMA Investing LLC: 1,290
Versant Capital Management, Inc: 399
Wealth Enhancement Trust Services, Inc.: 0
BlackRock, Inc.: 23.89 M
108.95% of Biocryst Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 344.82 M shares in the last 24 months. This purchase volume represents approximately $2.97 B in transactions.